Luye Pharma Group: Luye Pharma Grants Exeltis Exclusive Comm

BASEL, Switzerland, March 31, 2022 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into agreements with Exeltis Pharma

Related Keywords

China , Mexico , Japan , Poland , Switzerland , Spain , Japanese , Luye Pharma , Exeltis Pharma , Insud Pharma , Bruno Delie , Exeltis Pharmaceuticals Holding , Luye Pharma Group , Prnewswire Luye Pharma Group , Women Health , Alzheimer Disease International , Alzheimer Association , Insud Pharma Group , Pharma Group , Luye Pharma Switzerland , Rivastigmine Multi Day Transdermal Patch , General Manager , Central Nervous System , Disease Facts , Alzheimer Report , Luye , Dharma , Group , Migrants , Exeltis , Exclusive , Ommercialization , Tights , Nnovative , Lzheimer , Disease , Treatment , Ivastigmine , Ulti , Transdermal , Watch ,